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AbstrACt
Objectives This feasibility study aimed to assess the 
acceptability of inspiratory muscle training (IMT) in 
people with chronic obstructive pulmonary disease 
(COPD) who declined pulmonary rehabilitation (PR) as a 
potential treatment option or precursor to PR. Objectives 
were to assess attitudes to IMT, PR and alternatives 
to PR; factors inluencing adherence with IMT and 
acceptability of outcome measures, research tools and 
study protocol.
Design A pragmatic, mixed methods, prepost feasibility 
study was conducted. Recruitment took place over a 
4-month period. Participants were followed up for a period 
of 6 months.
settings IMT sessions and assessments were conducted 
in the domiciliary setting.
Participants Inclusion criteria: people over the age of 
35, stable COPD, Medical Research Council Dyspnoea 
scale of 3 or above, declined PR. Exclusion criteria: 
history of spontaneous pneumothorax, incomplete 
recovery from a traumatic pneumothorax, asthma, known 
recently perforated eardrum, unstable angina, ventricular 
dysrhythmias, cerebrovascular event or myocardial 
infarction within the last 2 months. Participants were 
selected from a purposive sample. Of the 22 potential 
participants screened, 11 were recruited and interviewed. 
Ten participants commenced IMT. Seven participants 
completed the follow-up assessment.
Intervention Eight weeks of IMT twice a day, 5 days 
a week with visits once weekly by a physiotherapist. 
Unsupervised IMT twice a day three times a week until 
follow-up at 6 months.
Outcomes Acceptability of IMT and the study process was 
explored via semi-structured interviews. Adherence with 
IMT was assessed by the Powerbreathe K3 device and 
participant diaries. Uptake of PR was identiied.
results IMT was found to be acceptable. Adherence was 
explored. Four people went on to participate in PR.
Conclusions Feasibility was established. A randomised 
controlled trial is warranted to establish eficacy and cost-
effectiveness of IMT in those who decline PR and IMT as 
an intervention to promote uptake of PR.
trial registration number NCT01956565; Post-results.
IntrODuCtIOn
Chronic obstructive pulmonary disease 
(COPD) is associated with high levels of 
morbidity and mortality and is a significant 
burden on health resources.1 Pulmonary 
rehabilitation (PR) is a highly evidence-
based, cost-effective therapeutic intervention 
involving education and supervised exer-
cise for people with COPD.2–4 PR should be 
offered to people with COPD with function-
ally limiting breathless and can be repeated 
annually.1 However, PR uptake is poor. The 
national PR audit5 identified that in the 
2013/2014 financial year, of the estimated 
446 000 people with COPD with Medical 
strengths and limitations of this study
 Ź The prepost design was appropriate to establish 
feasibility.
 Ź Mixed methods allowed triangulation of data.
 Ź Objectives were met and inspiratory muscle training 
was found to be acceptable.
 Ź The feasibility study design generated suficient 
data to warrant a larger pilot study.
 Ź Study design and sample size were appropriate to 
establish feasibility only, inference of results is not 
recommended.
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Research Council (MRC) Dyspnoea scale of 3 or above 
in England and Wales, there were approximately 68 000 
referrals for PR and only 42% of those referred went on 
to complete the programme. Some factors associated with 
PR non-adherence have also been linked to higher levels 
of healthcare utilisation and poor compliance with other 
therapies.6–8 Interventions to enhance PR uptake9 10 must 
take into account factors associated with disengagement, 
such as anxiety and beliefs about capability.11 
Inspiratory muscle training (IMT) may be an accept-
able treatment choice for those who decline PR, partic-
ularly for those with severe COPD or those who fear 
exercise-induced breathlessness, as it can be performed 
while seated in the home.12 IMT involves increasing the 
workload of the inspiratory muscles by inspiring against 
an external targeted load.13 Inspiratory muscle weakness 
is common in COPD14 15 and IMT has been shown to 
strengthen the inspiratory muscles demonstrated by an 
increase in maximal inspiratory pressure (PiMax).16
There is some debate surrounding the theory of IMT17 
and the British Thoracic Society guidelines18 do not 
currently advocate IMT as a precursor to PR or as an alter-
native for those who decline PR. However, meta-analyses of 
IMT for COPD has demonstrated clinical benefits.13 16 19–21 
Dyspnoea has been seen to improve in people with COPD 
when IMT has been used alone,16 19 in conjunction with 
exercise13 and following PR.22 23 Significant improvements 
in health-related quality of life (HRQOL) of people with 
COPD have been demonstrated when IMT was compared 
with control16 19 and when IMT was used following 
PR.23 However HRQOL was not enhanced by adding 
IMT to exercise.16 Meta-analyses found exercise toler-
ance to improve significantly when IMT was compared 
with control.13 16 Evidence surrounding improvements 
in exercise tolerance when IMT is added to exercise 
therapy is conflicting and appears to be dependent on 
baseline inspiratory muscle weakness.13 16 20 A multicentre 
randomised controlled trial (RCT)24 added IMT to PR 
for patients with baseline weakness. Although no differ-
ence was found in the primary outcome measure (6 min 
walk test), they found a 50% increase in their secondary 
measure (constant workrate endurance cycling) and 
reduced dyspnoea at isotime on the cycle test in those 
receiving IMT in addition to PR. One meta-analysis has 
compared outcomes of IMT in those with a baseline inspi-
ratory muscle pressure of above and below 60 cmH
2
O and 
found that initial PiMax did not seem to affect results.21 
Evidence on the impact of IMT on healthcare utilisation 
in people with COPD is limited. One RCT25 found that 
IMT did not reduce admissions but reduced length of 
stay and primary care consultations. However, the study 
was small (n=42) and although participants were not 
receiving an additional exercise programme, it was not 
clear whether participants had declined PR.
If IMT is found to be acceptable as a precursor or 
alternative to PR for those who decline, there could be 
cost savings to the NHS and clinical benefits to users. 
A comprehensive analysis of the clinical-effectiveness 
and cost-effectiveness of IMT in people with COPD who 
decline PR is warranted, commencing with a feasibility 
study to establish adherence and acceptability in this 
potentially non-concordant and disengaged population.
AIm
This feasibility study aimed to assess the acceptability of 
IMT in people with COPD who declined PR.
ObjeCtIves
1. To assess attitudes to IMT, PR and other potential al-
ternatives to PR.
2. To assess factors that influence adherence with IMT.
3. To assess acceptability of outcome measures, research 
tools and study protocol.
methODOlOgy
The feasibility study was a pragmatic exploratory study 
incorporating a mixed methods approach using quan-
titative and qualitative research methods.26 27 The study 
design was a non-blinded pretest post-test single-group 
experimental design28 with qualitative data collected by 
conducting semi-structured interviews.29 The COM-B 
theoretical framework was used to aid coding and anal-
ysis.11 Triangulation was conducted using the protocol 
adopted by Farmer et al.30
method
Sample
The feasibility study aimed to recruit 10 people declining 
PR who agreed to IMT. People who declined the feasi-
bility study were asked if they would be interviewed to 
explore barriers to participation. A small sample size was 
deemed appropriate to establish acceptability. Purposive 
sampling31 was implemented, identifying service users 
declining PR. Inclusion criteria: people over the age of 35, 
with stable COPD (having had no exacerbation needing 
antibiotics or steroids in the preceding 4 weeks) with 
breathlessness on MRC Dyspnoea scale32 of 3 or above 
and who declined PR. Exclusion criteria were: history of 
spontaneous pneumothorax, incomplete recovery from a 
traumatic pneumothorax, asthma, known recently perfo-
rated eardrum, unstable angina, ventricular dysrhyth-
mias, cerebrovascular event or myocardial infarction 
within the last 2 months. The research was performed 
within Community Services, Sheffield Teaching Hospitals 
(STH) NHS Foundation Trust. All assessments and IMT 
were conducted in the participant’s own home. Three of 
the interviews were conducted with spouses present.
Recruitment
Eligible participants were identified by clinicians within 
Community Services and the Respiratory Medicine 
Directorate of Sheffield Teaching Hospitals. Partici-
pants expressing an interest were then approached by 
the research team via telephone and sent the participant 
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information sheet and consent form. A mutually conve-
nient date was set to gain informed consent in person. 
Recruitment took place over a 4-month period.
Intervention
Participants performed 8 weeks of IMT strength training 
using the Powerbreathe K3 device. Training was 
progressed within the participant’s capability up to 60% 
PiMax. Participants inhaled through the mouthpiece of 
the device at high velocity from residual volume to total 
lung capacity, 30 times, twice a day, 5 days per week.33 
Inhalations through the device were initially paced every 
30 seconds to assess symptoms and capability. Participants 
then aimed to progress to three sets of 10 consecutive 
inhalations through the device (reducing training time 
to under 5 min). Training was titrated and progressed in 
accordance with the weekly PiMax assessment by the phys-
iotherapist (independent from the research team). This 
weekly visit for the first 8 weeks also allowed supervision 
of IMT to ensure optimal technique and that 30 inhala-
tions could be achieved on the new settings. After 8 weeks 
training, the participants were reassessed and advised to 
continue training unsupervised, twice a day, three times 
per week for a further 18 weeks33 until 6-month follow-up. 
In the event that training was interrupted due to an exac-
erbation of COPD, participants had the option to recom-
mence IMT and continue with the remainder of the study.
Patient and public involvement
The original research question was developed following 
anecdotal feedback from service users who had declined 
PR. The Sheffield ‘Breathe Easy Group’ and the STH 
Therapeutics and Palliative Care Patient Panel were 
consulted. Two people with COPD were also invited to 
be on the steering group. This PPI contributed to accept-
ability of study design, choice of outcome measures and 
development of participant information and consent 
forms. The results of the study were disseminated to the 
Breathe Easy Group. Study participants will each receive 
a copy of the publication.
Outcome measures
Recruitment
Recruitment and rate of attrition data were collected to 
establish feasibility.
Adherence
Adherence with IMT was measured using the electronic 
Powerbreathe K3 and participant diaries. The K3 records 
number of sessions, load, power, volume and T-Index 
(an indicator of effort). The diary was used to record the 
number of sessions completed and duration of training. 
Adherence data were collected at each visit during 
the 8-week training period by the physiotherapist and 
monthly in the follow-up period by a therapy assistant.
Acceptability
Semi-structured interviews lasting approximately an hour 
were conducted at baseline. The interview topic guide was 
piloted within the feasibility study and explored attitudes 
to IMT, treatment preferences and opinions regarding 
study design and outcome measures measured at base-
line, 8 weeks and 6 months. Interviews were recorded and 
transcribed verbatim. A shorter follow-up interview was 
conducted at 6 months addressing attitudes to the IMT 
intervention and study design and engagement or future 
intention to engage with other services (eg, PR).
The acceptability of the following outcome measures 
(to be used in any subsequent RCT) were also assessed.
Validated questionnaires included the self-administered 
Chronic Respiratory Disease Questionnaire,34 the COPD 
Assessment Test,35 the Hospital Anxiety and Depression 
scale36 and the EQ5D.37 Participant diaries were used to 
measure healthcare utilisation (antibiotic/steroid use). 
Spirometry was performed according to professional38 
and national39 guidelines using the MicroMedical 
MicroLab. Spirometry was used to establish severity and 
to monitor progression of COPD throughout the study. 
Inspiratory muscle strength (PiMax) was measured from 
residual volume using the MicroRPM (Micromedical). 
PiMax was also measured weekly during the first 8 weeks 
in order to establish progression of training and titrate 
training intensity. Limitations of measuring PiMax40 
were addressed by measuring sniff nasal pressure which 
reduces the occurrence of falsely identifying inspiratory 
muscle weakness.41 Activity monitoring was measured 
using the validated Sensewear (Bodymedia) accelerom-
eter.42 The device captured total energy expenditure in 
calories, number of steps, time spent sitting, time spent 
lying, time spent sleeping, average metabolic equivalent 
of task (METS), active energy expenditure (calories used 
above 3 METS) and duration of moderate and above 
moderate physical activity (time spent above 3 METS). 
The device was worn for 7 days with data analysed from 
five full days of use.
Outcome measures were measured at baseline, 8 weeks 
and 6 months, with the exception of the EQ5DL, which 
was measured at baseline and at 6 months as would reflect 
extrapolation of utility store in a larger study.
Data analysis
Qualitative data obtained from the semi-structured 
interviews was analysed using NVivo V.11 software (QSR 
International). Framework analysis43 using the COM-B 
theoretical framework11 was employed in the develop-
ment of the coding tree. Adherence rate was calculated 
by dividing the number of sessions completed by the 
prescribed number of sessions. Descriptive statistics were 
used to interpret recruitment and attrition rate.
relexivity
The interviewer was Cath O’Connor, a female Clinical 
Specialist Respiratory Physiotherapist (MSc Clinical 
Research, MSc Respiratory Physiotherapy) with postgrad-
uate training in qualitative research. The interviewer had 
clinical experience in both IMT and PR. The interviewer 
had no relationship with those involved prior to the study 
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and the goals of the research were explained during the 
informed consent process.
ethICs
The study was conducted in accordance with standards 
set out in Good Clinical Practice (GCP)44 and Depart-
ment of Health guidelines.45
results
recruitment and attrition
Eleven participants consented to IMT (figure 1) (recruit-
ment rate 2.5 per month). An 11th participant was 
recruited due to the dropout of a participant before base-
line assessment. Demographics are displayed in table 1. 
Attrition rate was 27 % at 8 weeks and 36% at 6 months 
(figure 1).
Adherence
Eight participants completed the 6 months IMT training 
programme, however, only seven were available for 
follow-up assessment. Adherence data are reported in 
table 2. Results were skewed due to overtraining by some 
participants. Participants training ranged between 48% 
and 126% of their expected sessions in the first 8 weeks 
with 481 sessions out of an expected 579 completed. 
Overall adherence with prescribed sessions for the 
6-month period was 76% (not including overtraining). 
In the supervised period, three participants (33%) 
performing IMT had completed all of their prescribed 
sessions and seven (77%) completed >70% of sessions. In 
the unsupervised period (weeks 9–26), 905 sessions out 
of an expected 987 were completed. Three participants 
(37.5%) had completed all of the prescribed sessions 
in the follow-up period and four (50%) had completed 
>70%. Delays surrounding device retrieval accounted for 
an increase in expected sessions for some participants; 
this was attributed to staff availability.
Intensity and effects of Imt
Intensity of IMT was recorded weekly for the first 8 weeks 
and then after approximately every 30 sessions (K3 data 
storage 36 sessions). The load for IMT was progressed weekly 
for the first 8 weeks. Progression of training (figure 2) was 
limited by exacerbations of COPD and other comorbidi-
ties. P9 was ill in week 1 and therefore commenced training 
in week 2. P11 was ill in week 3 and did not perform any 
sessions, therefore the load is recorded as 0. P3 developed 
comorbidities that impacted on training and worsened as 
the study progressed. Data regarding intensity of IMT are 
displayed in figures 3 and 4. Figures 5-7 display training data 
(based on the load set at the 8-week assessment) in relation 
to PR uptake and improvement in PiMax. P7 was ill at the 
8-week assessment and therefore training load for weeks 
9–26 was titrated according to the previous training session’s 
recorded PiMax. One participant particularly struggled with 
training progression due to anxiety and recurrent exacerba-
tion (P11).
Interview data
Interview data surrounding acceptability was analysed 
using the COM-B theoretical framework,11 which defines 
data in terms of Capability (psychological and physical), 
Opportunity (social and physical) and Motivation (reflec-
tive and automatic) and the impact that these have on 
Behaviour. The COM-B framework was used to establish 
why PR had been declined and whether IMT was accept-
able. Table 3 summarises the key barriers to PR and IMT 
arising from the qualitative analysis.
reasons for declining Pr
Capability
The interviews highlighted a lack of information or 
poor retention of information surrounding PR. Reasons 
for declining PR included reporting no recollection 
of being offered the service, physical limitations and 
Figure 1 Consort diagram. IMT, inspiratory muscle training; 
n, number; URTI, upper respiratory tract infection.
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misinformation surrounding PR location. One partic-
ipant dropped out after the assessment session of PR, 
as they had not perceived that the PR group exercise 
sessions would be different to the assessment walk test:
I thought I could do that at home…but they didn’t 
explain anything else after… I just come home and 
I just though well I could walk round cones in here 
can’t I…they didn’t explain anything to me. P10 
baseline
Some participants did not feel that they had the phys-
ical capability to do PR. Three participants were house-
bound. One participant had an above knee amputation, 
one had severe arthritis and another suffered from angina 
and had restricted mobility. Breathlessness was perceived 
to be a significant physical barrier to exercise, although 
one participant felt that this could have been addressed 
if exercise was performed at the right level. Two partic-
ipants had been advised against doing exercise in rela-
tion to physical capability, one by a physiotherapist and 
another by a doctor.
Opportunity
Participants did not feel that they were socially supported 
to attend PR. Those with supportive families were reluc-
tant to ask for help. Others reported less support and 
understanding from family members.
Some of the younger participants felt that age influ-
enced their decision to decline group PR:
Table 1 Demographics and baseline observations
Participant
Age 



















1 59 M 23.2 2 95 0.85 31 3.64 58 Declined
2 72 F x 4.5 90 0.58 35 1.56 39 Declined
3 65 M 22 3 94 0.84 29 2.86 57 11
4 62 M 22.6 3 93.5 1.47 52 2.91 80 59
5 75 F 38.7 0 92 0.84 40 1.85 39 15
6 68 M 32.7 1 88.5 0.61 23 1.35 31 Declined
7 58 F 32 2 94 1.35 59 3.34 63 Unrepeatable
8* 56 F x x x x x x x X
9 71 M 24.7 3 90 0.66 25 1.53 72 Declined
10 67 F 29 0 95 1.1 62 2.33 60 52
11 71 M 23.7 0.5 88.5 0.75 30 3.21 36 Unrepeatable
*Participant dropped out after initial interview prior to baseline measures.
BMI, body mass index; FEV1, forced expiratory volume in 1 s; FVC, forced vital capacity; PiMax, maximum inspiratory pressure; SaO
2
, oxygen 
saturation; VC, vital capacity.
Table 2 Adherence
Participant
Weeks 1–8 Weeks 9–26
Days Sessions
Expected 
sessions Adherence (%) Days Sessions
Expected 
sessions Adherence (%)
1 30 53 42 126 x x x x
2 58 63 81 77.8 185* 70 159.1 44
3 58 52 81.2 64 120 67 103.2 65
4 45 57 63 90 120 58 103.2 56
6 52 77 72.8 106 144 201 123.84 162
7 50 64 70 91.4 154 95 132.44 72
9 47 59 65.8 90 142 188 122.12 154
10 50 73 70 104 152 201 130.72 154
11 54 36 75.6 48 131 25 112.66 22
*Delay in equipment collection.
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I just sometimes think when I go to places like that, 
it’s telling me I’m past my sell by date (laughs). P10 
baseline
One participant overcame their concerns about the 
age group by making a ‘buddy’. Recommendations 
were made by one of the younger participants for a PR 
group orientated towards those under 60 years. However, 
two of those stating that they felt too young for the PR 
group were over 60 years. It was perceived that a group 
for younger participants, or those with less severe COPD, 
might have allayed fears that participants expressed about 
the prognosis of COPD and prospective use of oxygen.
Eight participants interviewed at baseline mentioned 
that physical opportunity in terms of transport was a 
barrier to group PR. Concerns were raised about having 
to get more than one bus to their nearest venue, distances 
between drop-off and venue, especially if a hill was 
involved, and the additional weight of carrying oxygen on 
the bus:
If I was to go to Springs (PR venue) now, because 
it’s right at the top of the hill I would have to get a 
bus into town, then get the tram to Manor Top. P01 
baseline
One participant stated that the combined travel time 
and class time was a waste and that the exercise could be 
performed at home. Not all participants were aware of 
community transport. Of those who knew about commu-
nity transport, one participant felt that it would be too 
expensive, and two others felt that there was an age 
stigma associated with the service. The two participants 
who owned their own car did not perceive transport to be 
a barrier to PR.
Motivation
Participants declining PR felt that they were doing activi-
ties and did not all feel that PR was necessary:
Well I go out every day for a walk round anyway so… 
I can do it I’ll do it myself. P04 baseline
Breathlessness on exercise was a concern to the majority 
of participants, although it was unclear from the inter-
views whether these emotional concerns were reflective or 
Figure 2 Training progression: load (weeks 1–8). P, participant.
Figure 3 Training intensity: average load, volume and power 
(weeks 1–8). PiMax, maximal inspiratory pressure; VC, vital 
capacity.
Figure 4 Training intensity: average load, volume and power 
(weeks 9–26). PiMax, maximal inspiratory pressure; VC, vital 
capacity. 
Figure 5 PR uptake, adherence (weeks 9–26) and change 
in PiMax at 6 months. n/a, not appropriate; PiMax, maximal 
inspiratory pressure; PR, pulmonary rehabilitation. 
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automatic. Supervision by staff experienced with COPD 
management and tailored programmes were felt to be 
a necessity with regard to safety of exercise. However, 
concerns associated with travelling to a PR venue super-
seded this need for supervision.
Acceptability of Imt
Capability
Knowledge of IMT was extremely limited, most having 
never heard of the device prior to the study yet despite 
this, lack of knowledge was not perceived to be a barrier 
to IMT:
I only saw it in paper…and I thought oh that’s al-
right…so I think it was £135.99 or something like that 
but I’d have paid it…If I’d thought it were going to 
do the trick…you’d pay it wouldn’t you. P10 baseline
Participants were not aware that IMT devices were avail-
able on prescription and concern was raised about the 
lack of information about the options available given to 
people with COPD. Participants stated that they would 
like to be made aware of all management options open 
to them.
Prior to the study, participants felt that if a prompt to use 
IMT was required it would be from a spouse. Participants 
mentioned that the development of routine would rein-
force their behaviour and this was reiterated at follow-up.
The majority of those interviewed felt that they had 
the physical capability and skills to use IMT. Problems 
encountered included initial difficulty with the IMT tech-
nique (quickly resolved) and thirst on performing the 
training (alleviated by having a drink at hand). Neck pain 
after using the device was reported by a participant with 
severe arthritis and one participant cited recurrent infec-
tions as a barrier to adherence. No other physical limita-
tions were reported.
Opportunity
IMT participants felt supported by staff, yet some felt they 
would be reluctant to ring staff if there was a problem.
Factors that influenced acceptability and adherence of 
IMT included problems with the IMT device included the 
inspiratory valve sticking and problems with the filters, 
particularly when training load exceeded 50% PiMax. 
These issues were addressed by changing the filters, having 
the devices checked and, where appropriate, lowering 
the level of resistance. One participant reported that the 
battery ran out quickly. Others reported no problems.
Interviewees felt that they would have the time to do 
IMT, although commitments varied significantly with 
some doing voluntary work or attending appointments 
and others having no commitments and welcoming a new 
activity. The environment of therapy appeared to have a 
high impact on acceptability of IMT. Interviewees liked 
the fact that they could do the treatment in their own 
home:
(It’s) a lot better really because I haven’t go the get 
up and go to go (out) and it frustrates me, everything 
does so therefore with the way I am, it’s been better. 
P02 follow-up
One participant would not have got involved in the 
study if it had not been in their home due to issues with 
the weather and time of year. If a treatment was to be in 
a venue, most participants felt that this should be at their 
local GP surgery.
Figure 6 PR uptake, T-Index (weeks 9–26) and change in 
PiMax at 6 months. n/a, not appropriate; PiMax, maximal 
inspiratory pressure; PR, pulmonary rehabilitation; T-Index, 
amount of work achieved during a session expressed as a 
percentage of the maximal potentially achievable work. 
Figure 7 PR uptake, training load (weeks 9–26) and change 
in PiMax at 6 months. n/a, not appropriate; PiMax, maximal 
inspiratory pressure; PR, pulmonary rehabilitation.
Table 3 Barriers to IMT and PR
COM-B domain
Capability Opportunity Motivation
















Technical issues No barriers 
identiied
IMT, inspiratory muscle training; PR, pulmonary rehabilitation.
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Motivation
A number of participants reported symptoms of depres-
sion, including low self-esteem. However, confidence to 
undertake IMT was high. Goals of IMT included being in 
control of the breathlessness, associated with activities of 
daily living, hobbies and social and leisure activities:
I just would love to be that little bit better…so I can 
do more…makes me feel good, makes my family 
proud of me… and spend more time with my grand-
son. P07 baseline
Participants wanted to improve their health and goals 
linked closely with beliefs about the consequences of 
IMT.11 46 Participants viewed IMT as a novel therapy and 
were willing to give IMT ‘a chance’. In contrast to periph-
eral exercises, it was recognised that IMT could directly 
impact on breathing. Despite several of the participants 
suffering from anxiety, no specific concerns about IMT 
were raised. Participants reported that subjective and 
objective improvements in health status would reinforce 
IMT behaviour and felt that IMT was important if it could 
help their symptoms.
At 6 months follow-up, three participants described 
benefits at the end of the study in terms of breathing effi-
ciency, increased exercise tolerance, improved inhaler 
technique and reduced inhaler usage:
I weren’t going out at all…something’s given me the 
confidence and I think it was this (IMT) you know… 
Oh I’m more or less going out once a week now. P02 
follow-up
One participant found benefits with IMT initially in 
terms of increased activity, but felt that these did not last. 
Three others perceived no benefit with IMT. Adherence 
with IMT was affected for one particularly anxious partici-
pant who had not used the device due to fear that it would 
cause infection; however, at 6 months follow-up this fear 
was reported to have been unfounded. Two participants 
had used the device but attributed lack of benefit to other 
comorbidities or infections during the study.
Behaviour
The target behaviour was adherence with the IMT inter-
vention. Adherence was variable and reduced once 
supervision ceased (table 2). However, some participants 
overtrained during the unsupervised maintenance period 
due to perceived benefits. Five participants accepted the 
offer for an IMT device to be prescribed for long-term 
usage when offered and four participants went on to 
participate in PR. All four participants who went on to 
attend PR had an IMT adherence rate of >70% (three 
were 100% adherent) at the end of the 6-month study 





Convergence between findings regarding acceptability 
of the IMT intervention and study protocol is presented 
in table 4. Agreement was found on five components 
with partial agreement on four components.30 The IMT 
intervention was found to be acceptable by the majority 
of participants who commenced treatment, and this 
was supported by adherence with the device. The study 
protocol was generally acceptable with the exception of 
the paper diary and sniff testing (table 4).
DIsCussIOn
Barriers to PR echoed previous findings6 47 with trans-
port difficulties in particular a significant limitation 
to group PR attendance, but not an issue for receiving 
IMT. A key area that limited acceptance of PR was lack of 
knowledge of both its benefits and what the programme 
entails. Knowledge and comprehension of therapies was 
poor, whereas the desire to know about potential treat-
ment options was high. This may potentially mean that 
information was not given or as others have found that it 
was not retained.48 This highlights the need for effective 
methods of education and information delivery.
IMT was found to be acceptable. Fewer barriers to IMT 
were identified in comparison to PR in terms of Capability, 
Opportunity and Motivation. Participants were capable 
of learning the skills of IMT and, with the exception of 
one participant who dropped out with severe arthritis, 
physically capable of using the device. Participants had 
the physical and social opportunity to use IMT in terms 
of space and time. In keeping with barriers to PR,6 
depression and anxiety were cited as factors associated 
with dropout and non-adherence with IMT in this study. 
These barriers must be addressed in order to promote 
engagement with therapies. Despite depression and frus-
tration associated with their condition, participants were 
enthused and felt capable to try a device that did not 
involve a physical exercise assessment or general physical 
activity. Self-efficacy varied depending on the prospective 
target behaviour,49 participants reported low self-efficacy 
with PR and higher self-efficacy with IMT. All participants 
were motivated to use IMT at baseline, however, moti-
vation varied at follow-up and was associated with rein-
forcement in terms of perceived benefit. There are few 
qualitative studies surrounding IMT to compare these 
findings. Hoffman et al50 studied qualitative outcomes 
rather than acceptability.
In keeping with the findings of Hoffman et al50 (who 
conducted interviews with participants after 8 weeks of 
IMT), some participants reported improvements with 
IMT in terms of breathlessness and activity. In addition, 
Hoffman et al50 found improvements in communica-
tion, whereas we found self-reported improvement in 
improved inhaler technique and reduced inhaler usage. 
Communication was not explored in this study, but may 
be explored in prospective research.
IMT was felt to hold greater value than PR and lack 
of perceived benefit of PR reflected previous findings.6 
People felt that they were already as active as they could 
be, whereas IMT was novel. In addition, the value of IMT 
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in terms of targeting the inspiratory muscles to relieve 
breathlessness was more readily perceived than exercising 
peripheral muscles, such as the quadriceps.
To the authors’ knowledge, PR uptake following IMT 
has not been measured previously. Four of the partic-
ipants in this feasibility study went on to participate in 
PR after commencing IMT. This may have been due to 
increased knowledge and sense of importance of PR 
following input from the physiotherapist, enhancement 
in self-efficacy and confidence by achieving goals in terms 
of IMT performance or because health gains due to IMT 
enhanced physical capability to attend. Although not 
conclusive, there does appear to be a coherent ‘trend’ for 
those who were more adherent with IMT to attend PR 
(figure 5). Further research is warranted to identify which 
specific components of complex interventions meet the 
needs of the individual in order to enhance participation.
Concerns prior to the feasibility study that by declining 
PR participants may not be adherent with IMT were 
unfounded. Adherence with IMT varied and some 
participants overtrained (weeks 9–26). Several studies 
have evaluated adherence.24 25 51–57 However, compar-
ison to these studies is limited as they measured super-
vised sessions only, reported adherence by diary alone 
and conducted studies of shorter duration. Of those 
measuring supervised and unsupervised sessions elec-
tronically, our adherence at 8 weeks (85%) was lower 
than the findings of Langer et al58 (95%), but similar at 
follow-up (76%) with the findings of Charususin et al24 
(79.9%). Charususin et al24 did not follow participants 
beyond 3 months and therefore adherence cannot be 
directly compared. However, the findings are promising 
as populations of both Langer et al58 and Charususin et al's 
studies24 may have been more motivated as they included 
people attending PR.
A limitation of the Powerbreathe K3 device was that 
although it captured the number of sessions performed, 
it did not report on whether the prescribed 30 inhala-
tions were achieved within each session. The T-Index 
(figure 3) did to some extent indicate training quality as it 
represents the amount of work achieved during a session 
expressed as a percentage of the maximal potentially 




High adherence rates. Few devices 
replaced due to malfunction.
One withdrawal due to adverse effect.
Five requested an IMT device. Four 
participants went on to participate in 
PR.
Participants motivated at baseline to use 
the device with positive beliefs about 
consequences, goals and reinforcement. Few 
technical problems reported.
Feedback surrounding IMT was positive, 




Interviews All IMT participants agreed to 
interview at baseline.
Well received. Agreement
Diary Few completed. Diaries acceptable at baseline. At follow-up, 
participants forgot or did not wish to ill in the 
diary. Mixed views given regarding its value.
Partial 
agreement
Questionnaires Completed—few missing values. No problems reported. Agreement
Accelerometer Majority had no problem and were 
adherence with the device. One 
participant had eczema and could not 
wear the armband.
Some concerns raised at baseline. One 
participant thought it may be mistaken for 
an ‘ASBO’ device. No problems voiced by 
those who wore device. Accelerometry was 
preferable to a walk test.
Partial 
agreement
PiMax testing Completed with no adverse effects. No problems were reported in performing the 
inspiratory muscle strength manoeuvres.
Agreement




Spirometry Completed with no adverse effects. Participants reported that they had previously 
had dificulties with spirometry within their 
general care. No problems experienced 
during study spirometry.
Agreement
Visits Visits cancelled mainly due to 
participant illness.
Satisied with physiotherapists. The 
duration of the IMT session was acceptable. 
The number and duration of visits were 
acceptable. Feedback about staff was 
positive.
Agreement
 IMT, inspiratory muscle training. 
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achievable work. Charususin et al24 identified a signifi-
cant relationship between improvement in PiMax and 
training quality during IMT (ie, total inspiratory work 
performed/session, average peak power/session) as well 
as progression of training intensity. No formal statistics 
were performed as our study’s aim was to establish feasi-
bility rather than efficacy of IMT, as reflected by sample 
size and single group design. However, there do appear 
to be positive trends between change in PiMax and 
parameters associated with training intensity and quality 
(figures 6 and 7). Median change in PiMax was 17 cmH
2
O 
(31%) at 8 weeks and 12 cmH
2
O at 6 months (28%). This 
compares well with improvements in PiMax of 25% and 
29% on systematic reviews of IMT,16 21 but is lower than 
improvements of IMT being added to PR in the study by 
Charususin et al (42%).24
Feedback regarding the study process was positive 
and the IMT recruitment target was met. The main 
study processes requiring review are two of the outcome 
measures. The sniff test was declined by some partici-
pants. Others received it well, but some scores were unre-
peatable. It was felt that this measure was not feasible to 
be used in any subsequent pilot study. Participant diaries 
were described as acceptable at the baseline interview, 
however, at follow-up completion rate was poor. This was 
in keeping previous findings8 and possibly because the 
value of the diaries was not clearly perceived by partic-
ipants. Healthcare utilisation will be measured using 
healthcare records in any subsequent study.
strengths and limitations
Strengths of the study were that the aims of the study 
were met and recruitment to the IMT intervention was 
successful with limited promotion of the study. In addition, 
rich data were generated surrounding the acceptability of 
IMT, the study itself and how IMT may overcome some 
of the perceived barriers to PR. Although not formally 
assessed, saturation of data appeared to be met despite 
the small sample.59 Limitations included sample size and 
potential bias. Attrition rate was difficult to compare with 
other studies due to the variations in population and 
study duration. Our attrition rate was 36% at 6 months 
compared with 19% at 3 months in a recent multicentre 
study adding IMT to PR.24 Attrition with IMT was consid-
erably lower than attrition data surrounding PR. High 
levels of PR attrition in the clinical setting have reflected 
findings from research.60 Given that attrition from PR was 
identified as 58% on the National Audit5 and our popu-
lation were anticipated to have high risk of comorbidity, 
exacerbations of COPD and social barriers contributing 
to their declining PR, a high level of attrition might be 
expected. However, in such a small sample our findings 
are not transferable. A pilot study is warranted prior to 
any larger RCT to clarify attrition rate and provide data 
for sample size calculation. Retention and adherence in a 
larger RCT may be enhanced by incorporating a behaviour 
change component to the intervention. Bias may have 
been introduced in the following ways: respondent 
validation61 was not employed, coding was conducted 
by the interviewer alone, reasons for declining the study 
were not explored and purposive sampling is subject to 
selection bias.31 Electronic monitoring was used to assess 
adherence and is the ‘gold standard’ of measuring adher-
ence in inhalation therapy8; however, the K3 device only 
recorded the number of sessions performed and not the 
date or time of training limiting interpretation of results.
The pragmatic method and sample size was deemed 
appropriate to establish feasibility. However, a multiple 
case study approach31 may have aided linkage of the 
COM-B domains to adherence with IMT facilitating 
the identification of barriers to IMT and triangulation. 
Further research may incorporate realist evaluation in 
order to illuminate the mechanisms of this complex inter-
vention and the context of implementation.62 63
COnClusIOns
This feasibility study of IMT in those who declined PR met 
its aims and was successful in showing that IMT could be 
easily implemented and IMT proved acceptable to partic-
ipants. Adherence levels varied and the use of behaviour 
change techniques may need to be incorporated with 
IMT in future research. Descriptions of clinical improve-
ment were sufficient to justify a larger randomised trial 
in order to formally assess clinical and cost-effectiveness 
in those who decline PR. Barriers to PR were highlighted 
and consistent with previous findings. Of interest, four 
participants significantly altered healthcare behaviour 
and went on to participate in full PR programmes despite 
their initial refusal, warranting further investigation.
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